Member Info for shares123

They have to announce the reverse acquisition soon so that they can have a agm sorted out in December. InvestorMAN, have you have heard the process has moved forward?

Arysta LifeScience have walked away from selling and marketing of PHC Harpin αβ Seed Treatment as no one wants it. Ow dear. Still other products are in the pipeline.

Maytech Communications: is loss making (£-360k) in 2014. Sagacity solutions: profit 2014: £910k, (2013: £939k). 2014 Cash: £999,716M, (2013: £628,797k) I think Sagacity, Web services integration and Control F1 look the most interesting.

Control F1 looks good £2.1M turnover in 2015 (2014: 0.5M), so it is growing nicely. Redline turned profitable in 2014 (£12,096). WEB SERVICES INTEGRATION 2014 profit £756,391 (2013 £1.55M) They all seem nice little small companies. Maybe a couple of the companies could be bought and merged together. I am sure there is some synergy to be had.

Still a large sale overhang here apparently. It will pass once all the people who do not like the merger/dividend holiday have gone. Then back to 450p. It reminds me of Optimal payments as the same thing happened there recently.

The largest shareholder Richard Griffiths acquired his stake in Sarossa at average price of about 2.4p in 2011 from my analysis. That puts him underwater. I am wondering why he has not forced the price up (by restricting stock) to at least break even level by now. Perhaps it is because they still want to buy stock back. At 2.4p any buy backs they want to do would still be at a big discount NAV.

I agree £15 is a reasonable target price. Strong balance sheet and current ratio should mean it survives any large market turbulence. The high sensitivity troponin test, should help drive future growth in 2017 onwards. Been some papers talking about it recently. To quote the last interm report "Revenues from this test (Troponin) could easily grow to dwarf the current business." http://www.bbc.co.uk/news/health-30896795 http://www.bmj.com/content/350/bmj.g7873.full.print?

Someone seems to building a big stake in Bioventix at the moment.

Companies house shows Pref shares have now been cancelled (stated in annual report). https://beta.companieshouse.gov.uk/company/03248123/filing-history The company now has £100,000,000 shares at 1p. Hopefully, LSE can update the fundamental information tab.

Another 50,000 Bought today (£129.88k). Someone is building their stake.

241,033 shares (£620.66k) bought the day before the interms. I wonder if that was Woodford or Invesco.

Jobbio, Maytech and Sagacity Solutions seem to be MXCP's potential candidates who do not yet have a AIM listing. I hope they choose Sagacity for the rev. acquisition personally. Seems to be the most interesting with rapid growth in revenue and EBITDA.

Hi Matt, Have you seen the current ratio for this stock. It has a lovely balance sheet, dividend cover. What is not to like. For some reason LSE is not giving financial info for this. Go to morningstar they give you 5 years worth.

Hi Matt, No price target. I am in this for the long term. I like its financial characteristics, business structure/royalty payments. It is like abcam but more reasonably priced. How about you? Why are you here.

I noticed you have sent a few messages of encouragement to Mr Dobbie on twitter :)

Profits are significantly ahead of market market expectations

Court order has gone through at last (28th Aug). (Reduction of share capital, cancellation of share premium account and cancellation of capital redemption reserve.) https://beta.companieshouse.gov.uk/company/SC368538/filing-history

The lack of interest is probably good at this stage. It allows a big discount to NAV to form. SARS can then use up there cash pile buying back the stock at a large discount. Hopefully getting rid of the large share overhang. They will no doubt try to promote the company abit more once the cash is used up.

No the share is not suspended.

It amazes me how it is possible to suppress the prices of these small companies. Still price is recovering. All the way to 920p at least.